DICER1 and myelodysplastic syndrome: This aberrant activation of β-catenin signaling is also found in stromal cells of MDS patients along with DICER-1 dysregulation (Santamaría et al., 2012; Ozdogan et al., 2017) correlating with adverse prognosis (Bhagat et al., 2017).